Compare · IDXG vs MMM
IDXG vs MMM
Side-by-side comparison of Interpace Biosciences, Inc. (IDXG) and 3M Company (MMM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IDXG and MMM operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MMM carries a market cap of $89.06B.
- MMM has been more active in the news (12 items in the past 4 weeks vs 2 for IDXG).
- MMM has more recent analyst coverage (25 ratings vs 1 for IDXG).
- Company
- Interpace Biosciences, Inc.
- 3M Company
- Price
- -
- $170.81+0.05%
- Market cap
- -
- $89.06B
- 1M return
- -
- +4.66%
- 1Y return
- -
- +13.01%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- n/a
- News (4w)
- 2
- 12
- Recent ratings
- 1
- 25
Interpace Biosciences, Inc.
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.
3M Company
3M Company develops, manufactures, and markets various products worldwide. It operates through four business segments: Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. The Safety and Industrial segment offers personal safety products, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules to industrial, electrical, and safety markets. The Transportation and Electronics provides electronics, such as display materials and systems, electronic materials solutions; automotive and aerospace, and commercial solutions; advanced materials; and transportation safety products to transportation and electronic original equipment manufacturer customers. The Health Care segment offers medical and surgical supplies, skin health and infection prevention products, oral care, separation and purification sciences, health information systems, drug delivery systems, and food safety products to healthcare industry. The Consumer segment provides home improvement, home care, and consumer health care products, as well as stationery and office supplies to various consumers. This segment is also involved in the retail auto care business. It offers its products through various e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers, as well as directly to users. 3M Company has a strategic collaboration with Merry Maids in residential cleaning sector; and collaborations with The Infectious Disease Research Institute and Duke Human Vaccine Institute to create a vaccine candidate with potential to provide protection against multiple variants of SARS-CoV-2. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.
Latest IDXG
- SEC Form DEFA14A filed by Interpace Biosciences, Inc.
- SEC Form DEF 14A filed by Interpace Biosciences, Inc.
- SEC Form PRE 14A filed by Interpace Biosciences, Inc.
- Interpace Biosciences, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Interpace Biosciences, Inc.
- Interpace Biosciences Announces First Quarter 2026 Financial and Business Results
- Amendment: SEC Form 10-K/A filed by Interpace Biosciences, Inc.
- Interpace Biosciences, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-K filed by Interpace Biosciences, Inc.
- Interpace Biosciences Announces Fourth Quarter and Full Year 2025 Financial and Business Results
Latest MMM
- SEC Form 144 filed by 3M Company
- SEC Form 10-Q filed by 3M Company
- 3M Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- 3M Reports Second-Quarter 2026 Results; Increases Full-Year Guidance
- 3M upgraded by Analyst with a new price target
- 3M and Microsoft announce strategic partnership to advance AI data center infrastructure and enterprise transformation
- Scotch™ Brand launches Scotch Kids® Tape for young creators
- 3M Announces Upcoming Investor Event
- 3M Young Scientist Challenge Names 10 Finalists for 2026 National Competition
- Group President Bauer Wendy A exercised 7,952 shares at a strike of $159.96 and covered exercise/tax liability with 3,558 shares, increasing direct ownership by 94% to 9,086 units (SEC Form 4)